Micro-fluidic chip, preparation method thereof and molecular measurement method using micro-fluidic chip

Through the design of microfluidic chips, the sliding of upper and lower chips and the optimization of micropore structures, the problems of low loading rate and multiple detection of microspheres are solved, and efficient biomolecular detection is achieved, suitable for multiple detection of proteins and nucleic acids, and the detection is improved Sensitivity and versatility.

CN118925814AActive Publication Date: 2024-11-12SHANGHAI JIAOTONG UNIV

Patent Information

Application Number
CN202310536757.1
Authority / Receiving Office
CN · China
Patent Type
Applications(China)
Current Assignee / Owner
Filing Date
2023-05-12
Publication Date
2024-11-12
Estimated Expiration
2043-05-12

AI Technical Summary

Technical Problem

In the prior art, microsphere loading rate is low, and it is difficult to realize multiple digital biological detection and multiple index detection of multiple biological molecules. The existing digital detection system cannot be applied to general detection of proteins and nucleic acids at the same time.

Method used

A microfluidic chip is designed to control fluids through the relative sliding of the upper and lower chips, reducing the dead volume of the fluid channel structure, and improving the loading rate of magnetic beads by controlling the micropore size and using fluorocarbon compounds to achieve step-by-step loading. and multiple samples are suitable for multiple detection of proteins and nucleic acids.

Benefits of technology

The microsphere loading rate is significantly improved to 90%, and multiple digital biomolecule detection of more than 20 levels is achieved, which reduces background signals, enhances detection sensitivity and versatility, and can be used for multi-index detection of proteins and nucleic acids at the same time.

✦ Generated by Eureka AI based on patent content.

Smart Images

  • Figure CN118925814A_ABST
    Figure CN118925814A_ABST
Patent Text Reader

Abstract

The invention discloses a micro-fluidic chip, a preparation method thereof and a molecular measurement method using the micro-fluidic chip. The micro-fluidic chip comprises an upper chip and a lower chip, the lower surface of the upper chip can be attached to the upper surface of the lower chip, and the upper chip and the lower chip can relatively slide along the attached surfaces. A first fluid channel structure for loading a first reactant and a second fluid channel structure for loading a second reactant are arranged on the lower surface of the upper chip, and a microporous structure is arranged on the upper surface of the lower chip; when the upper chip and the lower chip slide relatively, the vertical projection of the first fluid channel structure or the vertical projection of the second fluid channel structure can coincide with the micropore structure, so that a first reactant and a second reactant enter the micropore structure step by step. The loading rate of the magnetic beads can be increased to about 90%, the detection performance is remarkably improved, in addition, the background value can be remarkably reduced through the step-by-step sample loading scheme, and the method has more remarkable advantages in multiple detection.
Need to check novelty before this filing date? Find Prior Art

Description

Technical Field

[0001] The present invention relates to the technical field of molecular detection, and in particular to a microfluidic chip and a preparation method thereof, and a molecular measurement method using the same. Background Art

[0002] Nucleic acids and proteins are the basic molecules that make up life and are involved in almost all physiological and pathological processes. Since the invention of polymerase chain reaction (PCR) and enzyme-linked immunosorbent assay (ELISA) in the 1980s, nucleic acids and proteins as biomarkers in clinical diagnosis are gradually gaining attention. In recent years, many studies have shown that the key roles played in the occurrence and development of diseases are often some proteins and nucleic acid molecules of various types but extremely low abundance. Traditional detection methods are difficult to detect, thus limiting people's in-depth research and utilization of them.

[0003] The single-molecule array (Simoa) technology was first proposed in 2010. Walt et al. used antibody-modified magnetic microspheres to capture antigens in samples and formed immune complexes on the surface of the magnetic microspheres. Then, a large number of magnetic beads were independently enclosed in femtoliter microreaction chambers for fluorescence catalysis. Due to the physical isolation between different microreaction chambers, the catalyzed fluorescent substrates were concentrated in femtoliter droplets and would not be diluted due to diffusion, making the local substrate concentration extremely high, thus enabling single-molecule signal amplification. Since the distribution of antigens on the surface of microspheres conforms to the Poisson distribution, each microsphere surface captures zero, one or more antigen molecules. Finally, by counting the ratio of positive microspheres to negative microspheres or the change in fluorescence intensity of positive microspheres, the absolute concentration of the protein in the original system can be calculated. This technology has increased the detection sensitivity of traditional ELISA by nearly a thousand times, and is currently widely used in the fields of tumor marker detection, neurodegenerative disease detection, and inflammatory and infectious disease detection. The above digital protein detection technology has significantly improved the sensitivity of protein detection, but the following problems still exist:

[0004] 1. The microsphere loading efficiency is extremely low. Regardless of whether the microcavity array or microdroplet is used as the isolation module, the loading efficiency of a single microsphere in the droplet is limited by the Poisson distribution, usually accounting for only about 10% of the total chambers. This causes a large number of microchambers or microdroplets to become invalid chambers, which not only wastes subsequent data analysis resources, but more importantly, in order to achieve higher detection sensitivity or a wide linear range, the total number of chambers has to be increased to meet the needs of practical applications, which in turn greatly increases the difficulty of manufacturing and increases the chip area, as well as a surge in the difficulty of matching the optical detection system.

[0005] 2. It is difficult to detect more than 10 proteins simultaneously in a single reaction. Usually, if the digital detection method wants to achieve ultra-high sensitivity and a wide linear range at the same time, at least tens of thousands of effective chambers are required for each target molecule (that is, there must be tens of thousands of isolation chambers loaded with a single microsphere). The more detection target multiplicity is required, the more effective isolation microchambers need to be formed. However, since the microsphere loading rate is limited by the Poisson distribution, in order to meet the number requirements of hundreds of thousands of effective isolation chambers, it is necessary to provide a total number of isolation chambers as high as millions or even tens of millions, which undoubtedly increases the redundant invalid analysis resources and the difficulty of chip processing and manufacturing. Therefore, how to overcome the limitations of the microsphere loading Poisson distribution, achieve a high microsphere loading rate in a limited isolation chamber, and achieve ultra-sensitive, wide linear range digital detection for simultaneous detection of about 20 target molecules has become one of the biggest challenges of current digital detection technology.

[0006] 3. Existing digital isolation chips cannot achieve multi-step sample addition reactions. As a universal digital protein detection tool platform, it not only needs to meet the application requirements of specific detection methodologies and specific raw materials, but also the versatility of the detection chip and the ability to be easily adjusted according to specific detection methodology requirements, that is, the flexibility of the detection platform is also crucial. For example, some enzymatic signal amplification reactions require step-by-step sample addition and precise control of reaction time due to their extremely fast reaction speeds, in order to overcome bottleneck problems such as the increase in background signal caused by the enzyme contacting the substrate first and then loading the microspheres, which in turn leads to reduced detection sensitivity.

[0007] Since 1999, when Vogelstein et al. proposed the concept of digital PCR and pointed out the development direction of digital PCR detection instrument research and development by using the method of limiting dilution of the sample amount in each reaction well in a 384-well plate and increasing the number of reaction wells for detection, the amplification method of nucleic acid has entered the era of absolute quantitative detection that no longer relies on standard substances as quantitative references from the qPCR technology that relies on relative quantification of standard curves, and has developed rapidly in recent years. At present, there are three main types of digital detection platforms for nucleic acids: microchamber array technology, microdroplet technology, and barcode single molecule counting and analysis technology. The microchamber array technology is represented by LIFE Technologies' QuantStudio3D digital PCR instrument. In the microfluidic chip, 20,000 microwell arrays with a diameter of 60 microns and a volume of 0.8nL are prepared. The sample to be tested is dispersed into the microwells by segmentation to form several independent reaction units, and then the microwells are sealed and amplified. Finally, the "presence" or "absence" of the amplification end point signal is read and counted and Poisson distribution statistics are used to obtain the concentration of the sample to be tested. Another type of technology that is currently in the mainstream is micro-droplet technology, such as Bio-Rad's QX200, RainDance, STILLA's Crystal digital PCR and other micro-droplet digital PCR instruments, as well as BEAMing (Beads, Emulsion, Amplification, Magnetics) digital nucleic acid detection technology based on droplets combined with magnetic bead capture amplification. Micro-droplet digital PCR technology uses microfluidic chips to quickly and consistently generate nanoliter to picoliter oil-in-water droplets and use them as reaction chambers to isolate nucleic acid molecules to be tested. Compared with microchamber array technology, its biggest advantage is that the number of droplets can be flexibly and continuously generated as needed, and even tens of millions of droplets can be generated (such as RainDance), so the sensitivity of nucleic acid detection can be significantly improved. In addition, the manufacturing method of microfluidic chips for droplet generation is also simpler and more controllable. The third type is the fluorescent barcode nucleic acid single molecule counting and analysis system represented by Nanostring's nCounter. The main principle is that the nucleic acid molecules to be tested are hybridized with the capture probe and the reporter probe labeled with a four-color fluorescent barcode to form a hybridization complex, which is then fixed on the detection chip and each hybridization complex is arranged on the chip surface through an electric field. Finally, the type and quantity of the barcodes are detected separately through a microscopic fluorescence imaging system to achieve multiple, absolute quantitative counting detection of the target nucleic acid molecules.Since the fluorescent barcode probe molecules are labeled with 4 different fluorescent nucleic acid molecular clusters and arranged in a certain order, each barcode has 6 fluorescent clusters, which can form 4096 barcode probes. In theory, it has the ability to detect more than 4000 target nucleic acids at the same time. It is currently the system with the highest detection multiplex in a single reaction of digital nucleic acid detection. However, the operation of this system is complicated, the reaction of hybridization to form a complex needs to be overnight, and the cost of multi-coded multi-color reporter probes is extremely expensive, which is not conducive to its application as a daily detection method in clinical practice.

[0008] Whether it is a digital PCR detector based on microchamber array technology or microdroplet technology, although it is unmatched by other nucleic acid detection technologies in achieving high-sensitivity detection, there are still some drawbacks that are difficult to overcome due to the instrument design principle itself:

[0009] (1) None of them have solved the problem of multiple (>10 or more) nucleic acid detection in the era of precision medicine. These digital detection systems are limited by the fluorescence detection channel. It is difficult to load a large number of excitation light sources and fluorescence detection channels in the limited space of the optical detection module. Currently, the detection channel of digital PCR is only 4 colors at most, that is, a single tube can only detect 4 nucleic acid molecules at the same time.

[0010] (2) The goal of equivalent amplification has not been achieved in multiple nucleic acid amplification. Given the limitations of traditional nucleic acid amplification methodology, the more types of target nucleic acids need to be detected in a single reaction (single tube), the more primers there are in the conventional multiple primer amplification method, the more likely it is that primers will interfere with each other and form primer dimers, making it difficult to ensure that the amplification efficiency of different nucleic acid molecules to be tested remains consistent, thus greatly reducing the detection sensitivity and specificity. The bigger problem is that the product concentration level is likely to deviate from the concentration level of the original target nucleic acid molecule due to inconsistent amplification efficiency.

[0011] As previously reviewed and analyzed, digital detection systems for low-abundance proteins and nucleic acids have brought unprecedented changes in the discovery and confirmation of new biomarkers, early diagnosis of diseases, prognosis assessment, recurrence monitoring, and medication guidance in the era of precision medicine. However, there are still two major challenges:

[0012] (1) A universal, simple and controllable digital detection system that is applicable to both proteins and nucleic acids is in urgent need of breakthroughs. This may be because nucleic acids and proteins are two different types of target molecules, and the detection methodologies are completely different, making it difficult to achieve the unification of two very different methodologies with one detection system.

[0013] (2) Single-reaction (single-tube) multiplex (more than 10 target molecules) digital detection systems are in urgent need of breakthroughs. Currently, both digital PCR detection systems and protein digital detection systems are difficult to achieve simultaneous detection of more than 10 target molecules in a single-tube reaction. Summary of the invention

[0014] The technical problem to be solved by the present invention is to overcome the defects of the prior art such as low microsphere loading rate, difficulty in realizing multiple digital biological detection, and difficulty in realizing digital multi-index detection of multiple biological molecules, and to provide a microfluidic chip and its preparation method and a molecular measurement method using the same.

[0015] The present invention solves the above technical problems through the following technical solutions:

[0016] The present invention provides a microfluidic chip, comprising an upper chip and a lower chip, wherein the lower surface of the upper chip can be fitted with the upper surface of the lower chip, and the upper chip and the lower chip can slide relatively along the fitted surfaces, a first fluid channel structure for loading a first reactant and a second fluid channel structure for loading a second reactant are provided on the lower surface of the upper chip, and a microporous structure is provided on the upper surface of the lower chip, and when the upper chip and the lower chip slide relatively, the vertical projections of the first fluid channel structure or the second fluid channel structure can be overlapped with the microporous structure respectively, so that the first reactant and the second reactant can enter the microporous structure step by step.

[0017] The present invention utilizes the relative sliding of the upper and lower chips to manipulate the fluid, without the need for a complex fluid manipulation structure, and greatly reduces the dead volume used for fluid manipulation in the fluid channel structure, reducing the dead volume in the fluid channel structure to less than 40% of the total sample volume; and the present invention controls the size of the micropores so that each micropore can only carry a single magnetic microsphere, and the excess microspheres can be washed away by fluorocarbon compounds, thereby breaking through the limitations of the Poisson distribution and increasing the loading rate of the microspheres. Through the above two methods, the present invention increases the loading rate of magnetic beads from 5-10% of traditional technology to about 90%, significantly improving the detection performance.

[0018] In addition, the present invention adopts a step-by-step loading scheme, and the reactants are added step by step, so that the reaction will not start before the blocking due to premature mixing of the first reactant and the second reactant, resulting in an increase in background signal or even the appearance of false positive signals. Therefore, the step-by-step loading scheme of the present invention can significantly reduce the background value and has a more significant advantage in multiple detection.

[0019] Preferably, the microporous structure comprises a plurality of micropores, the first reactant comprises a magnetic microsphere bound with a molecule to be detected, and the micropore can be used to accommodate a single magnetic microsphere.

[0020] Preferably, the diameter of the micropores is 1 μm-100 μm, and the depth is 1 μm-100 μm; more preferably, 5 μm-10 μm, and the depth is 3 μm-8 μm, and the diameter of the magnetic microspheres is 3-6 μm.

[0021] Preferably, the number of the micropores is 10,000 to 1,000,000, and more preferably 400,000 to 800,000, so that the number of effective chambers, i.e., the closed micropores loaded with magnetic microspheres, can meet up to twenty-fold molecular detection.

[0022] Preferably, the vertical projection contours of the first fluid channel structure and the second fluid channel structure can overlap with the contour of the micropore structure, so that when the upper chip and the lower chip are in the primary loading position and the secondary loading position, the first fluid and the second flow channel can overlap with the micropore array respectively.

[0023] Preferably, the first reactant includes magnetic microspheres bound to molecules to be detected, the second reactant includes a signal precursor capable of reacting with the magnetic microspheres to produce a detectable signal, the first fluid channel structure has a first depth, and the second fluid channel structure has a second depth less than the first depth.

[0024] By adopting a larger first depth, when loading at the first loading position, the discrete magnetic microspheres injected into the first fluid channel structure can have a higher vertical projection density, thereby increasing the probability of the magnetic microspheres falling into the micropore structure and improving the utilization rate of the micropores.

[0025] By adopting a smaller second depth, the probability of the oil seal being damaged during fluid manipulation and the probability of generating liquid bubbles can be reduced, thereby improving the efficiency of sealing the micropores.

[0026] In some embodiments, the first depth is 10 μm-200 μm, and the second depth is 10 μm-200 μm.

[0027] Preferably, the first depth is 50 μm-175 μm, and the second depth is 50 μm-175 μm.

[0028] More preferably, the first depth is 175 μm, and the second depth is 50 μm.

[0029] Preferably, a hydrophobic layer is provided on the surfaces of the first fluid channel structure, the second fluid channel structure and the microporous structure.

[0030] Preferably, the material of the hydrophobic layer is linear polydimethylsiloxane molecules.

[0031] Therefore, the chip material, surface treatment, chip structure and reagents involved in the microfluidic chip can be compatible with the signal amplification method of digital protein and nucleic acid detection, can be used for protein detection incubated at room temperature, and can also withstand PCR reactions that require dozens of thermal cycles, making the microfluidic chip a universal detection device for proteins and nucleic acids.

[0032] The present invention also provides a method for preparing a microfluidic chip, which is used to prepare the microfluidic chip as described above, and the preparation method comprises the following steps:

[0033] S10: etching the first fluid channel structure and the second fluid channel structure on the upper chip, wherein the first fluid channel structure has a first depth, the second fluid channel structure has a second depth, and the first depth is greater than the second depth;

[0034] S20: etching the micro-hole structure on the lower chip;

[0035] Wherein, step S10 specifically includes:

[0036] S11: forming a first etching area on the chip covered with the protective layer to remove the protective layer, wherein the first etching area corresponds to the contour of the first fluid channel structure;

[0037] S12: etching the first etching region until the etching depth of the first etching region reaches the difference between the first depth and the second depth;

[0038] S13: forming a second etching area on the upper chip covered with the protective layer to remove the protective layer, wherein the second etching area corresponds to the contour of the second fluid channel structure;

[0039] S14: further etching the first etching region and the second etching region until the etching depth of the first etching region reaches the first depth, and the etching depth of the second etching region reaches the second depth.

[0040] Preferably, after step S20, the method further includes:

[0041] S30: preparing a hydrophobic layer on the upper chip and the lower chip after etching.

[0042] The present invention also provides a molecular measurement method, which is applicable to the microfluidic chip as described above, and is used to perform quantitative detection on the molecules to be measured.

[0043] Preferably, the molecule to be detected is a protein or a nucleic acid.

[0044] Preferably, when the molecule to be detected is a protein, the first reactant includes a magnetic microsphere bound to the molecule to be detected, the second reactant includes a signal precursor, and the magnetic microsphere can generate a detectable signal after binding to the signal precursor, and the molecular measurement method includes the following steps:

[0045] S100: Assembling an upper chip and a lower chip, and placing the lower surface of the upper chip in contact with the upper surface of the lower chip;

[0046] S200: sliding the upper chip and the lower chip relative to each other so that the vertical projection of the first fluid channel structure overlaps with the microporous structure;

[0047] S300: injecting the magnetic microspheres into the first fluid channel structure to allow the magnetic microspheres to settle in the microporous structure;

[0048] S400: injecting a first fluorocarbon compound into the first fluid channel structure to close the microporous structure;

[0049] S500: injecting a signal precursor into the second fluid channel structure, and sliding the upper chip and the lower chip relative to each other so that the second fluid channel structure overlaps with the microporous structure, so that the signal precursor enters the microporous structure and combines with the magnetic microspheres to generate a detectable signal;

[0050] S600: injecting a second fluorocarbon compound into the second fluid channel structure to secondary seal the microporous structure;

[0051] S700: Detect the signal emitted by the magnetic microspheres, and calculate the concentration of the molecule to be detected based on the signal.

[0052] Preferably, the fluorescent substrate is resorufin-β-D-galactopyranoside, and the enzyme is β-galactosidase.

[0053] Preferably, the molecule to be detected is bound to the magnetic microspheres modified with capture antibodies.

[0054] Preferably, the signal precursor includes a fluorescent substrate, and the magnetic microspheres are also bound to an enzyme capable of cleaving the fluorescent substrate to generate a fluorescent signal after binding to the molecule to be detected.

[0055] Preferably, step S700 includes:

[0056] The fluorescent positive signal of the magnetic microspheres is read, and the concentration of the molecule to be tested is calculated according to the micropore ratio of the fluorescent positive signal in the micropore structure, the Poisson distribution data of the molecule to be tested on the magnetic microspheres, and the input amount of the magnetic microspheres.

[0057] Preferably, the first fluorocarbon compound is a mixture of FC-40 and Novec 7100, and the volume ratio of FC-40 to Novec 7100 is 1:4. The mixture has a high surface energy, can effectively drive away excess magnetic microspheres, close micropores without affecting the magnetic microspheres and solution inside the micropores, and can also be completely removed from the top of the micropore structure as the sliding proceeds, without remaining on the lower chip surface or leaking into the adjacent second fluid channel structure.

[0058] Preferably, the second fluorocarbon compound is FC-40, which is less volatile than the first fluorocarbon compound and can ensure that the micropore array is always in a closed state during the signal amplification process, without exposing the micropores due to the volatilization and drying of the fluorocarbon compound.

[0059] When the molecule to be detected is a nucleic acid, the molecular measurement method comprises the following steps:

[0060] S1000: assembling the microfluidic chip so that the first fluid channel structure and the second fluid channel structure on the upper chip and the micropore structure on the lower chip are filled with liquid;

[0061] S2000: sliding the upper chip and the lower chip relative to each other so that the first fluid channel structure overlaps with the microporous structure;

[0062] S3000: injecting a PCR reaction solution into the first fluid channel structure, and then injecting a first fluorocarbon compound into the first fluid channel structure to seal the micropores;

[0063] S4000: injecting perfluoropolyether into the first fluid channel structure to replace the first fluorocarbon compound;

[0064] S5000: performing PCR amplification on the microfluidic chip;

[0065] S6000: Calculate the nucleic acid concentration according to the fluorescent signal in the microporous structure.

[0066] The positive and progressive effects of the present invention are:

[0067] The present invention successfully breaks through the limitation of Poisson distribution on microsphere loading and achieves a microsphere loading rate of nearly 90%, which is significantly higher than the traditional technology with a loading rate of only 5-10%. The larger number of microspheres makes the detection sensitivity of this technology better than similar technologies, and the combination of fluorescent coded microspheres can achieve more than 20 multiple digital biomolecule detections;

[0068] The present invention innovatively realizes the multi-part loading of samples in hundreds of thousands of microwells, making the chip more versatile and applicable to a variety of different reaction principles. For example, in digital protein detection, the enzyme and substrate can be added to the microwells in steps, which reduces the need for time control in the operation and improves the stability of the reaction. Compared with the traditional loading method, the present invention can significantly reduce the false positive signals caused by premature contact between the enzyme and the substrate;

[0069] The present invention can realize digital multi-index detection of two biological molecules, nucleic acid and protein, in the same chip. BRIEF DESCRIPTION OF THE DRAWINGS

[0070] Figure 1 A top view of the upper chip;

[0071] Figure 2 is a top view of the lower chip;

[0072] Figure 3 is a schematic diagram of the first fluid channel structure overlapping with the microporous structure;

[0073] Figure 4 A schematic diagram of injecting a first fluorocarbon compound to push away excess magnetic microspheres;

[0074] Figure 5 Schematic diagram of magnetic microspheres settling in a microporous structure;

[0075] Figure 6 A schematic diagram of injecting a signal precursor into the second fluid channel structure;

[0076] Figure 7 This is a schematic diagram of the microfluidic chip when it is stationary;

[0077] Figure 8 Schematic diagram of the fluorescence signal emitted in the microporous structure;

[0078] Fig. 9 It is a curve diagram showing the relationship between the amount of magnetic beads input and the utilization rate of the magnetic beads;

[0079] Fig.10 This is a comparison chart of the background signals of the first and second loadings at different magnetic bead input amounts, antigen input amounts, and magnetic bead sedimentation times;

[0080] Fig.11 This is a comparison chart of the number of positive wells corresponding to DNA samples at different dilution multiples;

[0081] Fig.12 It is the relationship between the dilution multiple and the measured DNA concentration;

[0082] Fig.13 It is the signal value view of interleukin-6 standard samples with different concentrations;

[0083] Description of reference numerals:

[0084] Chip 100

[0085] First fluid channel structure 110

[0086] The second fluid channel structure 120

[0087] Chip 200

[0088] Microporous structure 210

[0089] First Reactant 300

[0090] Second reactant 400

[0091] Magnetic microspheres 500 DETAILED DESCRIPTION

[0092] The present invention is further described below by way of examples, but the present invention is not limited to the scope of the examples.

[0093] Example 1

[0094] like Figure 1 and Figure 2 The present invention provides a microfluidic chip, which includes an upper chip 100 and a lower chip 200. The upper chip 100 and the lower chip 200 can be made of glass, plastic, metal or composite materials. In the present invention, the upper chip 100 and the lower chip 200 are both made of glass.

[0095] The lower surface of the upper chip 100 and the upper surface of the lower chip 200 can be bonded to each other, and the bonded upper chip 100 and lower chip 200 can slide relative to each other along their bonded surfaces.

[0096] The lower surface of the upper chip 100 is provided with a first fluid channel structure 110 for loading a first reactant 300 and a second fluid channel structure 120 for loading a second reactant 400. The first reactant 300 includes a magnetic microsphere 500 combined with a molecule to be detected, and the second reactant 400 includes a signal precursor.

[0097] The upper surface of the lower chip 200 is provided with a microporous structure 210, which includes a plurality of micropores, each of which has a diameter of 5μm-10μm and a depth of 3μm-8μm. Correspondingly, the diameter of the magnetic microsphere 500 is 3-6μm, so that a single micropore can only accommodate one magnetic microsphere 500.

[0098] The first fluid channel structure 110 , the second fluid channel structure 120 and the microporous structure 210 can be manufactured by wet etching, dry etching, injection molding, hot pressing or machining.

[0099] like Figure 3 and Figure 6 When the upper chip 100 and the lower chip 200 slide relative to each other, the vertical projection of the first fluid channel structure 110 or the second fluid channel structure 120 can overlap with the microporous structure 210 respectively.

[0100] The operation method of this microfluidic chip is as follows:

[0101] Combination Figure 8 , assemble the upper chip 100 and the lower chip 200 face to face, and align the first fluid channel structure 110 in the upper chip 100 with the microporous structure 210 of the lower chip 200. At this time, the upper chip 100 and the lower chip 200 are in a first loading position, and then the magnetic microspheres 500 are injected into the first fluid channel structure 110. After the magnetic microspheres 500 are precipitated into the microporous structure 210, fluorocarbon compounds are injected to push away the excess magnetic microspheres 500 and close the micropores. Then, the second fluid channel structure 12 0, slide the upper and lower chips 200 to align the second fluid channel structure 120 with the micropore structure 210, at this time the upper chip 100 and the lower chip 200 are in the secondary loading position, the signal precursor can be delivered to the micropores and mixed with the magnetic microspheres 500, wait for 5-30 seconds to complete the diffusion of the reactants, and then inject fluorocarbon compounds again to seal the micropores. At this point, the loading operation is completed, and the molecules to be tested in the sample can be quantified through subsequent signal amplification (constant temperature incubation catalysis or PCR amplification).

[0102] The present invention utilizes the relative sliding of the upper and lower chips 200 to manipulate the fluid, without the need for a complex fluid manipulation structure, and greatly reduces the dead volume used for fluid manipulation in the fluid channel structure, reducing the dead volume in the fluid channel structure to less than 40% of the total sample volume; and, by controlling the size of the micropores, the present invention enables each micropore to only carry a single magnetic microsphere 500, and the excess microspheres can be washed away by fluorocarbon compounds, thereby breaking through the limitations of the Poisson distribution and increasing the loading rate of the microspheres. Through the above two methods, the present invention increases the loading rate of magnetic beads from 5-10% of traditional technology to about 90%, significantly improving the detection performance.

[0103] In addition, the present invention adopts a step-by-step loading scheme to add the reactants step by step, so that the reaction will not start before the blocking due to premature mixing of the first reactant 300 and the second reactant 400, resulting in an increase in background signal or even the appearance of false positive signals. Therefore, the step-by-step loading scheme of the present invention can significantly reduce the background value and has a more significant advantage in multiple detection.

[0104] In this embodiment, the number of the micropores is preferably 400,000-800,000, so that the number of effective chambers, i.e., the closed micropores loaded with magnetic microspheres 500, can meet up to twenty-fold molecular detection.

[0105] In this embodiment, the first fluid channel structure 110 includes a first channel and a first injection port connected to the first channel, the second fluid channel structure 120 includes a second channel and a second injection port connected to the second channel, and the plurality of micropores in the micropore structure 210 are distributed in an array.

[0106] The first flow channel, the second flow channel and the micropore array have the same profile, so that when the upper chip 100 and the lower chip 200 are in the primary loading position and the secondary loading position, the first fluid and the second flow channel can overlap with the micropore array respectively. Specifically in the present invention, the size data of the first flow channel, the second flow channel and the micropore array are: length 15mm-22mm, width 1.5mm-3.5mm. Of course, the above dimensions are only specific embodiments of the present invention, and different dimensions can be used as needed.

[0107] In this embodiment, the first fluid channel structure has a first depth, and the second fluid channel structure 120 has a second depth different from the first depth. Specifically, the first depth is 50 μm-175 μm, and the second depth is 50 μm-175 μm.

[0108] By adopting a larger first depth, when loading at the first loading position, the discrete magnetic microspheres 500 injected into the first fluid channel structure 110 can have a higher vertical projection density, thereby increasing the probability of the magnetic microspheres 500 falling into the micropore structure 210 and improving micropore utilization.

[0109] By adopting a smaller second depth, the probability of the oil seal being damaged during fluid manipulation and the probability of generating liquid bubbles can be reduced, thereby improving the efficiency of sealing the micropores.

[0110] In this embodiment, the surfaces of the first fluid channel structure 110, the second fluid channel structure 120 and the microporous structure 210 are provided with a hydrophobic layer. The material of the hydrophobic layer is linear polydimethylsiloxane molecules. As a result, the chip material, surface treatment, chip structure and reagents involved in the microfluidic chip can be compatible with the signal amplification method of digital protein and nucleic acid detection, can be used for protein detection incubated at room temperature, and can also withstand PCR reactions that require dozens of thermal cycles. This makes the microfluidic chip a universal detection device for proteins and nucleic acids.

[0111] Example 2

[0112] The present invention also provides a method for preparing a microfluidic chip, which is applicable to the microfluidic chip as described above, and comprises the following steps:

[0113] S10: etching a first fluid channel structure 110 and a second fluid channel structure 120 on the upper chip 100, wherein the first fluid channel structure 110 has a first depth of 50 μm and the second channel structure has a second depth of 10 μm, or the first fluid channel structure 110 has a first depth of 100 μm and the second channel structure has a second depth of 50 μm, or the first fluid channel structure 110 has a first depth of 200 μm and the second channel structure has a second depth of 175 μm;

[0114] S20: etching a micro-hole structure 210 on the lower chip 200;

[0115] Specifically, step S10 specifically includes:

[0116] S11: forming a first etching region for removing the protective layer on the upper chip 100 covered with the protective layer, wherein the first etching region corresponds to the contour of the first fluid channel structure 110 and can be etched;

[0117] S12: etching the first etching region until the etching depth of the first etching region reaches the difference between the first depth and the second depth;

[0118] S13: forming a second etching region for removing the protective layer on the upper chip 100 covered with the protective layer, the second etching region corresponding to the contour of the second fluid channel structure 120, and the second etching region can be etched;

[0119] S14: etching the first etching region and the second etching region simultaneously until the etching depths of the first etching region and the second etching region reach a second depth.

[0120] By adopting the above-mentioned preparation method, a first fluid channel structure 110 and a second fluid channel structure 120 having a first depth and a second depth, respectively, can be prepared on the upper chip 100 .

[0121] In step S11, the protective layer includes a chromium layer and a photoresist layer sequentially plated on the upper chip 100, and the step of preparing the first etching area specifically includes:

[0122] Use AutoCAD software to design the chip structure and prepare a film mask corresponding to the outline of the first fluid channel structure 110. Place the mask on the upper chip 100 that has been plated with a chrome layer and a photoresist layer, and expose it under the parallel ultraviolet light of a photolithography machine;

[0123] Soak the exposed glass in 0.1 mol / L sodium hydroxide solution for 1 minute to remove the photoresist that reacts with ultraviolet light;

[0124] Subsequently, the glass was transferred to a dechroming solution for 1 minute to remove the chromium layer exposed by the removal of the photoresist, wherein the dechroming solution contained 0.6 mol / L perchloric acid and 0.365 mol / L cerium ammonium nitrate aqueous solution;

[0125] The treated glass is fully rinsed with deionized water and air-dried to obtain a first etching area after the chromium layer and the photoresist layer are removed.

[0126] In step S12, the step of etching the first etching area specifically includes:

[0127] The upper chip 100 after step S11 is placed in a constant temperature glass etching solution at 40°C for etching, and the shaker is kept shaking at a rate of 50 rpm. The glass etching solution contains 1 mol / L hydrofluoric acid, 0.5 mol / L ammonium fluoride and 0.75 mol / L nitric acid solution, and the etching rate is about 1.5-2 μm / min;

[0128] The channel depth is characterized by a step meter and the etching time is adjusted. When the etching depth reaches the difference between the first depth and the second depth, the chip is taken out.

[0129] In step S13, the preparation process of the second etching area specifically includes:

[0130] A second mask having the outline of the second fluid channel structure 120 is placed above the upper chip 100, and the alignment marks on the mask and the alignment marks on the chrome plate are observed under a microscope;

[0131] Expose the glass under parallel ultraviolet light again, and soak it in 0.1 mol / L sodium hydroxide solution for 1 minute to remove the photoresist part that reacts with ultraviolet light, and temporarily retain the chrome layer;

[0132] Rinse the treated glass thoroughly with deionized water and air dry;

[0133] After step S12 is completed, the upper chip 100 is taken out, washed with deionized water, and then placed in a chromium removal solution to remove the chromium layer exposed by the second exposure, thereby obtaining a second etching area.

[0134] Specifically, step S14 specifically includes:

[0135] The upper chip 100 that has undergone step S13 is further placed in the glass etching solution for etching until the etching depth reaches the second depth.

[0136] Specifically, the step S20 of preparing the lower chip 200 includes:

[0137] The chip structure is designed using AutoCAD software, and a chrome mask corresponding to the micro-hole structure 210 is prepared;

[0138] A photoresist with a thickness of 2-3 μm is spin-coated on the lower chip 200, and then the pattern on the chrome mask is transferred to the photoresist using a UV photolithography process. The single chip design in the mask contains 4 parallel microwell arrays. There are 281,200 microwells in a single array. Each microwell has a diameter of 4.25 μm, and the center distance between microwells is 10.25 μm.

[0139] The photolithographic substrate was etched using the inductively coupled reactive ion etching process. The main etching gases used were CHF3 and Ar. The etching rate was about 350nm / min, the etching time was about 10min, the etching depth was about 3.5um, and a micro-hole array with a diameter of 4.25μm and a depth of 3.5μm was processed. The depth tolerance was <±0.3μm.

[0140] The residual photoresist on the lower chip 200 is removed by combining acetone wet stripping and plasma dry stripping, and the substrate is diced into unit chips by mechanical cutting equipment.

[0141] In this embodiment, after step S20, the following steps are further included:

[0142] S30: preparing a hydrophobic layer on the etched upper chip 100 and the lower chip 200 .

[0143] Specifically, step S30 includes:

[0144] Wash the glass surface thoroughly with deionized water and dry it;

[0145] The chip was placed in a plasma cleaning instrument for surface plasma cleaning and activation. The generating gas used in the plasma cleaning instrument was air, the power was about 150w, the air pressure was about 50Pa, and the processing time was 2 minutes. Then the glass chip was quickly taken out and placed in a plastic culture dish containing 50μL dichlorodimethylsilane for vapor deposition. This step required a reaction at room temperature for 1 hour.

[0146] After the reaction is completed, rinse the chip surface with chloroform, acetone and ethanol, and air-dry it for later use.

[0147] Example 3

[0148] The present invention also provides a protein molecule measurement method, which is applicable to the microfluidic chip as described above, wherein the first reactant 300 input includes a magnetic microsphere 500 bound to the molecule to be measured, and the second reactant 400 input includes a signal precursor, and the magnetic microsphere 500 can generate a detectable signal after binding to the signal precursor. The molecular measurement method comprises the following steps:

[0149] S100: Assembling the upper chip 100 and the lower chip 200, and placing the lower surface of the upper chip 100 in contact with the upper surface of the lower chip 200;

[0150] Specifically, in the present invention, the microfluidic chip is immersed in a 0.05% Triton X-100 solution for cleaning, and then transferred to ultrapure water, the chip is disassembled, and the vessel is slightly shaken to replace the liquid inside the chip with ultrapure water, and then the upper chip 100 and the lower chip 200 are assembled again in the water phase. After the assembly is completed, the chip is taken out, and the relative positions of the upper and lower chips 200 are fixed with a dovetail clamp to complete the chip assembly;

[0151] S200: sliding the upper chip 100 and the lower chip 200 relative to each other so that the vertical projection of the first fluid channel structure 110 overlaps with the microporous structure 210;

[0152] S300: Combined Figure 3 , injecting magnetic microspheres 500 into the first fluid channel structure 110 , so that the magnetic microspheres 500 are deposited in the microporous structure 210 ;

[0153] Combination Figure 5 Specifically, in the present invention, after injecting the magnetic microspheres 500, it is necessary to stand for 2 minutes to allow the microspheres to settle into the micropore array below;

[0154] S400: Combined Figure 4 , injecting a first fluorocarbon compound into the first fluid channel structure 110 to close the microporous structure 210;

[0155] S500: Combined Figure 6 , injecting a signal precursor into the second fluid channel structure 120, relatively sliding the upper chip 100 and the lower chip 200 so that the second fluid channel structure 120 overlaps with the microporous structure 210, so that the signal precursor enters the microporous structure 210 and combines with the magnetic microspheres 500 to generate a detectable signal;

[0156] S600: injecting a second fluorocarbon compound into the second fluid channel structure 120 to secondary seal the microporous structure 210;

[0157] Specifically, in the present invention, after the micropores are sealed, the reaction needs to be carried out at room temperature for 3 minutes to allow the signal precursor and the magnetic microspheres 500 to fully react;

[0158] S700: Combination Figure 7 , detect the signal emitted by the magnetic microsphere 500, and calculate the concentration of the molecule to be tested based on the signal.

[0159] In this embodiment, the signal precursor includes a fluorescent substrate, and the magnetic microsphere 500 is also bound with an enzyme capable of cleaving the fluorescent substrate to generate a fluorescent signal after being bound to the molecule to be detected.

[0160] In this embodiment, the fluorescent substrate is resorufin-β-D-galactopyranoside, and the enzyme is β-galactosidase.

[0161] In this embodiment, the molecule to be detected includes a protein molecule, and the protein molecule is bound to the magnetic microsphere 500 modified with a capture antibody.

[0162] In this embodiment, the magnetic microsphere 500 combined with the molecule to be detected and the enzyme is prepared by the following method:

[0163] 1. Dilute the sample to be tested to different concentrations with sample diluent (10mM PBST + 1% casein sodium salt, pH = 7.4, 0.05% Tween-20), dilute the encoded microspheres coated with capture antibodies to 2*10^7 / mL, dilute the biotinylated detection antibody to 0.25μg / mL, and dilute the conjugate of streptavidin and β-galactosidase to 120pM;

[0164] 2. Vortex the diluted coded microsphere working solution for 30 seconds and ultrasonicate for 2 minutes. Add 25 μL of the microsphere working solution to a 2 mL centrifuge tube, add 100 μL of the protein sample to be tested, and then add 20 μL of the detection antibody dilution solution. After mixing, place it on a rotating reactor and rotate at 37°C for 30 minutes.

[0165] 3. Place the centrifuge tube in a desktop centrifuge and centrifuge for 5 seconds. Centrifuge the liquid on the centrifuge tube cap to the bottom of the centrifuge tube, place it on a magnetic rack, magnetically adsorb for 2 minutes, and remove the supernatant;

[0166] 4. Add 400 μL washing solution (10 mM PBST, pH 7.4, 0.05% Tween-20), shake for 30 seconds to mix, centrifuge for 5 seconds, place on a magnetic stand, magnetically adsorb for 2 minutes, remove the supernatant, and repeat this operation 4 times;

[0167] 5. Add 100 μL SβG diluent, mix well and place on a rotating reactor, and rotate at 37°C for 10 minutes;

[0168] 6. Place the centrifuge tube in a desktop centrifuge and centrifuge for 5 seconds. Centrifuge the liquid on the centrifuge tube cap to the bottom of the centrifuge tube, place it on a magnetic rack, magnetically adsorb for 2 minutes, and remove the supernatant;

[0169] 7. Add 400 μL washing solution, shake for 30 seconds to mix, centrifuge for 5 seconds, place on a magnetic stand, adsorb for 2 minutes, remove the supernatant, and repeat this operation 4 times;

[0170] 8. Add 5 μL of washing solution, pipette 5 times, resuspend and mix the prepared immune complex microspheres.

[0171] In this embodiment, the detection method for the molecule to be detected in S700 specifically includes the following steps:

[0172] The fluorescent positive signal of the magnetic microsphere 500 is read, and the concentration of the molecule to be tested is calculated according to the micropore ratio of the fluorescent positive signal in the micropore structure 210, the Poisson distribution data of the molecule to be tested on the magnetic microsphere 500, and the input amount of the magnetic microsphere 500.

[0173] In this embodiment, the first fluorocarbon compound is a mixture of FC-40 and Novec 7100, and the volume ratio of FC-40 to Novec 7100 is 1:4. The mixture has a high surface energy, can effectively drive away the excess magnetic microspheres 500, close the micropores without affecting the magnetic microspheres 500 and the solution inside the micropores, and can also be completely removed from the top of the micropore structure 210 as the sliding proceeds, and will not remain on the surface of the lower chip 200 or leak into the adjacent second fluid channel structure 120.

[0174] In this embodiment, the second fluorocarbon compound is FC-40, which is less volatile than the first fluorocarbon compound, and can ensure that the micropore array is always in a closed state during the signal amplification process, and the micropores will not be exposed due to the volatilization and drying of the fluorocarbon compound.

[0175] Example 4

[0176] This embodiment provides a method for detecting nucleic acid molecules, comprising the following steps:

[0177] S1000: Assembling the microfluidic chip so that the first fluid channel structure 110 and the second fluid channel structure 120 on the upper chip 100 and the microporous structure 210 on the lower chip 200 are filled with the liquid phase. Specifically, in the present embodiment, the upper and lower chips are first immersed in a 0.5%wt Triton X-100 solution, and the upper and lower chips containing the microstructures are closed in the solution, and then transferred to ultrapure water, and the chips are disassembled so that the Triton in the chip is fully replaced, and then the chip containing the structure is closed again, and transferred to an 80%wt glycerol solution, and the chip is disassembled so that the ultrapure water is fully replaced by the glycerol solution, and then the chip is closed again;

[0178] S2000: sliding the upper chip 100 and the lower chip 200 relative to each other so that the first fluid channel structure 110 overlaps with the microporous structure 210;

[0179] S3000: injecting a PCR reaction solution into the first fluid channel structure 110, and then injecting a first fluorocarbon compound into the first fluid channel structure to seal the micropores, wherein the first fluorocarbon compound is FC-40;

[0180] S4000: injecting perfluoropolyether into the first fluid channel structure 110 to replace the first fluorocarbon compound, the perfluoropolyether is specifically polyperfluoromethyl isopropyl ether (CAS No.: 69991-67-9), and its molar mass is 1800g;

[0181] S5000: placing the microfluidic chip on a flat-plate PCR instrument to perform PCR amplification;

[0182] S6000: Calculate the nucleic acid concentration based on the fluorescent signal in the micropore structure 210. Specifically in the present embodiment, after the amplification is completed, a fluorescent microscope is used to perform microscopic imaging of the fluorescent signal of the FAM channel in the micropore. Since the distribution of nucleic acid molecules in the micropores conforms to the Poisson distribution, the nucleic acid in the original sample can be absolutely quantitatively analyzed by counting the number of positive micropores and negative micropores.

[0183] The sequence and primer information used for PCR amplification are shown in Table 1; the PCR reaction system is shown in Table 2; and the PCR reaction conditions are shown in Table 3. The DNA template is the BK virus genome.

[0184] Table 1 Primers and probes

[0185]

[0186] Table 2 PCR reaction system

[0187] Components Volume (total volume 100 μL) ExTaq(Takara,RR001A) 2μL 10x ExTaq Buffer(Takara,RR001A) 10μL 2.5mM dNTP 8μL 10 μM forward primer 10μL 10 μM reverse primer 10μL 10 μM hydrolysis probe 10μL 20mg / mL BSA solution 5μL Ultrapure water 40μL template 5μL

[0188] The PCR reaction conditions are shown in the following table:

[0189]

[0190] Effect Example 1

[0191] The present invention characterizes the magnetic bead loading performance of the chip by analyzing the utilization rate of the micropores on the micropore array chip under different magnetic bead loading conditions (the number of micropores of a single wrapped magnetic bead / the total number of micropores). After the loading is completed, the loading state of the magnetic beads is observed by a fluorescence microscope, and the positioning of the magnetic beads can be achieved by detecting the green fluorescence signal emitted by the FITC molecules modified on the surface of the magnetic beads. By statistically analyzing the number of magnetic beads loaded on the chip under different conditions, the magnetic bead loading performance of the sliding micropore array chip can be evaluated.

[0192] Combination Fig. 9 In the present invention, the amount of magnetic beads input for each reaction is 62,500, 125,000, 250,000, 500,000 and 1,000,000 respectively. It can be seen that with the increase in the amount of magnetic beads input, the utilization rate of the micropores of the chip is significantly improved. When the amount of magnetic beads input reaches 1,000,000, the utilization rate of the micropores reaches 90%, which is significantly better than similar technologies (5-10%).

[0193] Effect Example 2

[0194] The present invention is used to analyze the background signal intensity under two different loading methods, namely, primary loading and secondary loading, and systematically characterizes the effects of different loading methods. The test includes the background signal intensity in the microporous structure under different magnetic bead input amounts, antigen input amounts, and magnetic bead sedimentation times.

[0195] The test structure is as follows Fig.10 As shown in the above figure, with the increase of the amount of magnetic beads and antigen input, the background signal of the single loading group was significantly enhanced and significantly higher than that of the secondary loading group; at different magnetic bead sedimentation times, the background signal of the single loading group was significantly higher than that of the secondary loading group. This result shows that the unique secondary loading workflow of the sliding microwell array chip can suppress the effect of pre-catalysis on the reaction signal-to-noise ratio, and can become a potential technical solution to eliminate false positive signals in multi-index detection.

[0196] Effect Example 3

[0197] The quantitative ability of digital PCR based on microwell array chips was evaluated by testing DNA samples with different dilution factors. In this experiment, DNA samples with 1, 4, 16 and 64 times dilution were tested and injected into the chip for PCR amplification. Fig.11 As shown in FIG. 1 , AD are the digital PCR result diagrams of the above different dilution multiples, wherein as the dilution multiple increases, the number of positive wells decreases significantly, as shown in FIG. Fig.12 As shown, there is a good linear relationship between the dilution factor and the measured DNA concentration.

[0198] Effect Example 4

[0199] like Fig.13 The present invention determines the signal value of interleukin-6 standard samples under different concentrations. Specifically, interleukin-6 standard samples with concentrations of 0.05, 0.25, 1.25, 6.25, and 31.25 pg / mL and a negative group were tested, with 3 replicates for each concentration. The lower limit of detection (LoD) and the lower limit of quantification (LoQ) are the sum of the average background signal of the negative group and 3 times and 10 times the standard deviation. The system LoD is calculated to be 5.3 pg / mL and the LoQ is 15.2 pg / mL.

[0200] Although the specific embodiments of the present invention are described above, it should be understood by those skilled in the art that this is only for illustration and the protection scope of the present invention is defined by the appended claims. Those skilled in the art may make various changes or modifications to these embodiments without departing from the principles and essence of the present invention, but these changes and modifications all fall within the protection scope of the present invention.

Claims

1. A microfluidic chip, comprising an upper chip and a lower chip, wherein the lower surface of the upper chip can be bonded to the upper surface of the lower chip, and the upper chip and the lower chip can slide relative to each other along the bonding surface, characterized in that: A first fluid channel structure for loading a first reactant and a second fluid channel structure for loading a second reactant are provided on the lower surface of the upper chip, and a microporous structure is provided on the upper surface of the lower chip. When the upper chip and the lower chip slide relative to each other, the vertical projection of the first fluid channel structure or the second fluid channel structure can overlap with the microporous structure respectively.

2. The microfluidic chip according to claim 1, characterized in that: The microporous structure comprises a plurality of micropores, the first reactant comprises a magnetic microsphere bound with a molecule to be detected, and the micropore can be used to accommodate a single magnetic microsphere.

3. The microfluidic chip according to claim 2, characterized in that: The diameter of the micropores is 1 μm-100 μm, the depth is 1 μm-100 μm, and / or the number of the micropores is 10,000-1,000,000.

4. The microfluidic chip according to claim 1, characterized in that: The vertical projection contours of the first fluid channel structure and the second fluid channel structure can coincide with the contour of the microporous structure, and / or the first fluid channel structure has a first depth, and the second fluid channel structure has a second depth smaller than the first depth.

5. The microfluidic chip according to claim 4, characterized in that: The first depth is 10 μm-200 μm, and the second depth is 10 μm-200 μm.

6. The microfluidic chip according to claim 5, characterized in that: The first depth is 175 μm, and the second depth is 50 μm.

7. The microfluidic chip according to any one of claims 1 to 6, characterized in that: A hydrophobic layer is provided on the surfaces of the first fluid channel structure, the second fluid channel structure and the microporous structure.

8. The microfluidic chip according to claim 7, characterized in that: The material of the hydrophobic layer is linear polydimethylsiloxane molecules.

9. A method for preparing a microfluidic chip, for preparing the microfluidic chip as claimed in any one of claims 1 to 8, characterized in that: The preparation method comprises the following steps: S10: etching the first fluid channel structure and the second fluid channel structure on the upper chip, wherein the first fluid channel structure has a first depth, the second fluid channel structure has a second depth, and the first depth is greater than the second depth; S20: etching the micro-hole structure on the lower chip; Wherein, step S10 specifically includes: S11: forming a first etching area on the chip covered with the protective layer to remove the protective layer, wherein the first etching area corresponds to the contour of the first fluid channel structure; S12: etching the first etching region until the etching depth of the first etching region reaches the difference between the first depth and the second depth; S13: forming a second etching area on the upper chip covered with the protective layer to remove the protective layer, wherein the second etching area corresponds to the contour of the second fluid channel structure; S14: further etching the first etching region and the second etching region until the etching depth of the first etching region reaches the first depth, and the etching depth of the second etching region reaches the second depth.

10. The method for preparing a microfluidic chip according to claim 9, characterized in that: After step S20, the method further includes: S30: preparing a hydrophobic layer on the upper chip and the lower chip after etching.

11. A molecular measurement method, characterized in that: The microfluidic chip as described in any one of claims 1 to 8 is used to quantitatively detect the molecules to be detected.

12. The molecular measurement method according to claim 11, characterized in that: The molecule to be detected is a protein or a nucleic acid.

13. The molecular measurement method according to claim 12, characterized in that: When the molecule to be detected is a protein, the first reactant includes a magnetic microsphere bound to the molecule to be detected, and the second reactant includes a signal precursor, and the magnetic microsphere can generate a detectable signal after binding to the signal precursor. The molecular measurement method includes the following steps: S100: Assembling an upper chip and a lower chip, and placing a lower surface of the upper chip in contact with an upper surface of the lower chip; S200: sliding the upper chip and the lower chip relative to each other so that the vertical projection of the first fluid channel structure overlaps with the microporous structure; S300: injecting the magnetic microspheres into the first fluid channel structure to allow the magnetic microspheres to settle in the microporous structure; S400: injecting a first fluorocarbon compound into the first fluid channel structure to close the microporous structure; S500: injecting a signal precursor into the second fluid channel structure, and sliding the upper chip and the lower chip relative to each other so that the second fluid channel structure overlaps with the microporous structure, so that the signal precursor enters the microporous structure and combines with the magnetic microspheres to generate a detectable signal; S600: injecting a second fluorocarbon compound into the second fluid channel structure to secondary seal the microporous structure; S700: Detect the signal emitted by the magnetic microspheres, and calculate the concentration of the molecule to be detected based on the signal.

14. The molecular measurement method according to claim 13, characterized in that: The signal precursor includes a fluorescent substrate, and the magnetic microspheres are further combined with an enzyme capable of cleaving the fluorescent substrate to generate a fluorescent signal after combining with the molecule to be detected, and / or the molecule to be detected is combined with the magnetic microspheres modified with a capture antibody.

15. The molecular measurement method according to claim 14, characterized in that: The fluorescent substrate is resorufin-β-D-pyranogalactoside, and the enzyme is β-galactosidase.

16. The molecular measurement method according to claim 13, characterized in that: Step S700 includes: The fluorescent positive signal of the magnetic microspheres is read, and the concentration of the molecule to be tested is calculated according to the proportion of micropores with fluorescent positive signals in the micropore structure, the Poisson distribution data of the molecule to be tested on the magnetic microspheres, and the input amount of the magnetic microspheres.

17. The molecular measurement method according to claim 13, characterized in that: The first fluorocarbon compound is a mixture of FC-40 and Novec 7100, the volume ratio of FC-40 to Novec 7100 is 1:4, and the second fluorocarbon compound consists of FC-40.

18. The molecular measurement method according to claim 13, characterized in that: The second fluorocarbon compound is FC-40.

19. The molecular measurement method according to claim 13, characterized in that: When the molecule to be detected is a nucleic acid, it comprises the following steps: S1000: assembling the microfluidic chip so that the first fluid channel structure and the second fluid channel structure on the upper chip and the micropore structure on the lower chip are filled with liquid; S2000: sliding the upper chip and the lower chip relative to each other so that the first fluid channel structure overlaps with the microporous structure; S3000: injecting a PCR reaction solution into the first fluid channel structure, and then injecting a first fluorocarbon compound into the first fluid channel structure to seal the micropores; S4000: injecting perfluoropolyether into the first fluid channel structure to replace the first fluorocarbon compound; S5000: performing PCR amplification on the microfluidic chip; S6000: Calculate the nucleic acid concentration according to the fluorescent signal in the microporous structure.

Citation Information

Patent Citations

  • Rotary microfluidic chip for nucleic acid extraction of biological samples

    CN109609345A

  • Method for generating liquid droplet array on microfluidic chip

    CN110643483A

  • Micro-fluidic chip and multi-step reaction method

    CN114289088A

  • Surfactant for PCR (Polymerase Chain Reaction) detection reagent as well as preparation method and application of surfactant

    CN115558097A

  • Digital ELISA (enzyme-linked immunosorbent assay) detection method for preventing fluorescence signal crosstalk

    CN116008523A

Cited By

  • PH value identification method, device and equipment based on micro-fluidic chip and storage medium

    CN121409955A